MYD88 and lymphoplasmacytic lymphoma: MYD88 Leu252Pro (formerly Leu265Pro) mutations are particularly related to lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM), which would not be expected to have a substantial bloodborne component26,32,33.